H
AVNS

Hexavest’s Avanos Medical AVNS Stock Holding History

Hexavest’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-150
Closed -$5K – 491
2016
Q2 		$5K Hold
150
– – ﹤0.01% 490
2016
Q1 		$4K Hold
150
– – ﹤0.01% 493
2015
Q4 		$5K Hold
150
– – ﹤0.01% 483
2015
Q3 		$4K Hold
150
– – ﹤0.01% 476
2015
Q2 		$6K Hold
150
– – ﹤0.01% 478
2015
Q1 		$7K Hold
150
– – ﹤0.01% 459
2014
Q4 		$7K Buy
+150
New +$5.89K ﹤0.01% 450

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Hexavest's AVNS Position: Q3 2016 in Review

Hexavest sold out of Avanos Medical (AVNS) in Q3 2016, closing a stake of 150 shares — an estimated $5K sold.

Hexavest first reported a position in AVNS in Q4 2014 and held it in 7 quarters. The position peaked at $7K in Q1 2015. 359 funds tracked by Wall St. Rank hold AVNS as of Q3 2016.

  • Hexavest reported no remaining Avanos Medical position as of Q3 2016 after selling out during the quarter.
  • Hexavest sold 150 Avanos Medical shares in Q3 2016, an estimated $5K.
  • Hexavest first reported a position in Avanos Medical in Q4 2014 and held it in 7 quarters.
  • Hexavest's Avanos Medical position peaked at $7K in Q1 2015.
  • 359 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2016.

Based on Hexavest's 13F filing for Q3 2016, filed 12 Oct 2016.